Plasma Therapy Market Manufacturer Landscape, Revenue, Volume Analysis and Segment Information up to 2030

 

Plasma Therapy Market Highlights

According to MRFR analysis, the global plasma therapy market is expected to cross USD 895.45 million by 2030 at a CAGR of 13.8%.

The global plasma therapy market is driven by several factors, such as the growing prevalence of immune deficiency disorders, autoimmune disorders, bleeding disorders and rising acceptance of plasma therapy in neurology and other therapeutic indications. The surge in the adoption of therapeutic protein drugs in the cure of a broad range of clinical symptoms. This is expected to rise as a potential for the market during the forecast period. Approvals around the globe for new plasma-derived therapies will increase the demand. Thus, the above-mentioned factors are anticipated to surge the growth of the global plasma therapy market soon. Technological advancements in the field and rising awareness among the population regarding the disease and availability of the treatment are pushing the market to new heights.

Plasma therapy has a wide application such as in the treatment of expanding list of life-threatening, debilitating, and chronic disorders. The therapies are used in the treatment of various diseases. The treatment includes immunoglobulins used to treat various diseases in individuals with autoimmune diseases and immune deficiencies.

Clotting-factor therapies are used for people with hemophilia B and A along with other blood-related disorders, and albumin is used in acute settings for the treatment of burns, trauma, shock, and others. plasma protein therapeutics association are highly used in replacement therapies to cure conditions, such as lack of a coagulation factor in Hemostasis. The deficiency can be due to autoimmune disorders or genetic, and it might occur as a complication of cancer. The clotting factor fibrinogen is used as replacement therapy for haemorrhagic diathesis in diseases like afibrinogenemia, dysfibrinogenemia, and hypofibrinogenemia.

Segmentation

The global plasma therapy market has been segmented into type, source, and application. By types, the market has been segregated into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure PRP segment demonstrates the largest revenue share of the global market owing to the reduced or no risks in the use of pure PRP. Furthermore, its ability to ameliorate the healing process of tendons, tissue, and bones is another key factor propelling the growth of pure PRP in the market.  The leukocyte rich PRP segment is anticipated to be the fastest growing market soon. This is attributed to the growth in the number of patients suffering from osteoarthritis of the hips and knee.

Based on source, the global plasma therapy market report has been classified as autologous and allogenic. The autologous segment accounts for the major share of the market. High awareness of plasma therapy and its approval as a possible remedy for healing tissues and bones are surging the development of the autologous source segment in the market.

Based on applications, the market is categorized into orthopedic, dermatology, and cardiac muscle injury, dental, and nerve injury. The dermatology segment is estimated to register the highest growth with considerable CAGR during the forecast period. This is attributed to the inclining number of patients with hair and skin-related conditions, rising beauty consciousness in the general population, and growing use of micro-needling for cosmetic purposes which is bolstering the segment's market growth.

Regional Analysis

North America holds the largest plasma therapy market share in 2021, owing to the availability of leading platelet rich plasma therapy product manufacturers, active participation of research and academic institutes to conduct advanced research and development activities, rising awareness toward benefits of platelet rich plasma (PRP) therapies, and assistance from regulatory authorities and government to encourage the use of PRP for medical applications. The well-developed healthcare infrastructure in the region, along with the availability of highly skilled professionals is influencing the market growth. The high awareness in the population in turn provides many plasma donors further fuelling market growth.

Asia-Pacific is anticipated to be the fastest-growing market during the forecast period due to large population in the region as well as the constant emergence of chronic diseases. These factors are expected to boost the market growth in the region. The developing healthcare facilities and active government participation for the improvement of public health are providing huge opportunities for the market. The outbreak of COVID-19 has enhanced the awareness regarding plasma therapy as it was used as a potential treatment, and India was one of the forerunning countries to adapt the therapy. The high number of disease patients in the region is a key contributor to the regional market growth. An increase in investment by the major market players in the region is also boosting the market in Asia-Pacific.

Furthermore, the growth of the market in the Rest of the World is attributed to the technological advancements in plasma therapy coupled with the prevalence of diseases throughout the region.

Plasma Therapy Market Players

The global plasma therapy market players are BioLife Plasma Services (US), Cambryn Biologics LLC (US), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB S.A (France), Bio Products Laboratory Ltd. (U.K.), China Biologic Products, Inc. (China), Octapharma (Switzerland), Arthrex, Inc. (US), DePuy Synthes Companies (US), Grifols S.A (Spain), Global Stem Cells Group, Inc. (US), Juventix Regenerative Medical LLC (US), and Celling Biosciences, Inc. (US) among others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Acute Care EHR Market Focuses on SWOT analysis, Synopsis, Development Plans 2020 to 2027

  Overview The acute care EHR slightly differ from the hospital and ambulatory EHR, generating patient information with all clinical details including the operating room, emergency department, ICU, and inpatient unit. Over the past decade, there has been a significant rise in the number of patients suffering from chronic diseases such as cancer, diabetes, heart disease, and stroke among others which are driving the acute care EHR market, increasing the number of caregiving facilities across the globe. Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come; Market Research Future (MRFR), in its recently published market forecast asserts that the global  acute care EHR market  will grow exponentially by 2023, registering approximately 7% CAGR during the forecast period (2020 – 2027). The global acute care EHR is majorly driven by the augmenting demand for the remote health monitoring for geriatric patient
Read more

mHealth Market Latest Study Focuses On Current, Future Innovations and Top Key Vendors | Forecast 2030

  Market Overview The wave of modernization in the healthcare sector has led to the penetration of the concept of mHealth greatly. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is forecasted to achieve a 36.5% CAGR in the upcoming forecast period. The robust growth pace in the wearable health device sector has increased the expansion of the  mHealth market  globally. Moreover, increased usage of smartphones is also playing a key role in the growth of the market. Also, patients are increasingly involved and aware of their treatments which is expected to further influence the mHealth market in the forecast period. Segmental Analysis The segmental evaluation of the mHealth market is carried out on the basis of therapeutics, applications, and region. On the basis of therapeutics, the mHealth market has been segmented into respiratory,
Read more

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth, Opportunity and Product Developments 2030 |MRFR

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device ma rket . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Regional Analysis The market in the Americas is expected to dominate t
Read more